Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Stockman432 who wrote (2076)	7/30/1998 2:00:00 PM
From: TJG	Respond to of 2395

Stockman... If the D1000 had marked improvements from the past then why haven't the shareholders been informed? fda.gov > here's some info that you should review..The CE mark gave way to distribution in Europe.Great! Have we heard of any mass demand for this revolutionary product to date? No..why? because it still is what it was.. If the D1000 was as important as we're made to think then every diabetic in Europe would have been after one already..IMHO the D3000 or better still the D4000 / generation three or four will mean significant changes and increases for BICO>> By significant increases I'm not talking about $.50 but rather $50.. If the company can keep it's head above water long enough to see this far.. TJG

To: Stockman432 who wrote (2076)	7/30/1998 2:44:00 PM
From: Terry D.	Respond to of 2395

Stockman, 5th, 6th, won't make a difference. Until outcome is given this stock won't move. CE approval and the distributor is on vacation. He sure takes the D1000 serious doesn't he. Luckily I'm only in for a few thousand dollars. If you can believe it, some posters have their retirement riding on this. I mean actual retirement, not early retirement. Problem with this company is soooo many press releases with never any follow through. Investors are wary and don't believe in the management anymore. Daytraders, MM making a killing right now. Day after day, slight rise then close at the open. What happened to the thermocleanse hospital in Arabia, rumors of dropping the FES, Bio Soc getting great reviews on oil spills in Arabia? Where are the reviews? Chem Cote 50 million a year potential, now in litigation. On and on. Like everyone, I'd like to get out with a profit, just stating the fact. Not bashing or cheer leading. Terry